For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research ...

A new way to treat asthma symptoms and even repair previously irreversible lung damage could be on the horizon following the ...

Amneal submits a BLA for a new Xolair biosimilar, promising affordable treatment options for asthma and allergies, enhancing ...

Teens play basketball outside on a hot day in summer 2023 in New York City after the state issued an air quality health advisory recommending active children and those with asthma limit time outside.

An FDA Decision for Amgen and AstraZeneca’s Tezspire in CRSwNP is slated for October 19: Why approval looks likely.

Early intervention with two asthma drugs may offer protection from pneumonia in patients infected with influenza, according to a new study published in PLOS Pathogens. Influenza pneumonia occurs when ...

People taking GLP-1 medications had better-controlled asthma overall, though there was no difference in lung function compared to those not taking GLP-1s. The study suggests that GLP-1 drugs may have ...

A promising new drug for treating asthma could not only reduce asthma symptoms but also improve lung function in patients, according to a new study. The results of the trial involving dupilumab, which ...

AstraZeneca said on Wednesday its asthma drug Fasenra failed to control the rate of flare-ups in patients with chronic obstructive pulmonary disease (COPD) in a late-stage study, in a setback to ...

AstraZeneca said on Friday it will sell its diabetes and asthma drugs direct to cash-paying U.S. patients at a discount of up ...

Only 1 in 10 of the prescriptions filled in the U.S. are for brand-name drugs; the vast majority are for generics, which are ...